61 related articles for article (PubMed ID: 35901948)
1. The Rate of Prostatic Involvement in Men Treated With Radical Cystectomy for Muscle Invasive Bladder Cancer.
Royal-Preyra B; Cury FL; Katib Y; Monsoor M; Brimo F; Kassouf W; Souhami L
Pract Radiat Oncol; 2023; 13(1):e68-e72. PubMed ID: 35901948
[TBL] [Abstract][Full Text] [Related]
2. Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study.
Brück K; Meijer RP; Boormans JL; Kiemeney LA; Witjes JA; van Hoogstraten LMC; van der Heijden MS; Donders AR; Franckena M; Uyl de Groot CA; Leliveld AM; Aben KKH; Hulshof MCCM
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):41-49. PubMed ID: 37517601
[TBL] [Abstract][Full Text] [Related]
3. Development and Internal Validation of a Nomogram Predicting Overall Survival Based on Log ODDS of Positive Lymph-Nodes for Post Radical Cystectomy Patients in Muscle Invasive Carcinoma of Bladder.
Patel KN; Salunke A; Sharma M; Puj K; Rathod P; Warikoo V; Bakshi G; Pandya SJ
Clin Genitourin Cancer; 2023 Jun; 21(3):e153-e165. PubMed ID: 36549982
[TBL] [Abstract][Full Text] [Related]
4. Propensity score matched survival analysis of octogenarians with muscle-invasive bladder cancer: chemoradiation compared to radical cystectomy.
Avudaiappan AP; Prabhakar P; Ganapathi H; VanderVeer-Harris N; Caso J; Garje R; Manoharan M
Can J Urol; 2023 Oct; 30(5):11686-11691. PubMed ID: 37838996
[TBL] [Abstract][Full Text] [Related]
5. Predictors of trimodality therapy in patients with muscle-invasive bladder cancer and effect on survival.
Tang Y; Lin L; Xiao Y; Meng L; Yang Y; Li X
Clin Transl Oncol; 2024 Feb; 26(2):446-455. PubMed ID: 37389736
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer Registry.
Richters A; Leliveld AM; Goossens-Laan CA; Aben KKH; Özdemir BC
World J Urol; 2022 Sep; 40(9):2275-2281. PubMed ID: 35778577
[TBL] [Abstract][Full Text] [Related]
7. Analysis of treatment of muscle invasive bladder cancer using the national cancer database: Factors associated with receipt of aggressive therapy.
Moon S; Pandya V; McDonald A; Basu A; Bae S; Ferguson JE
Urol Oncol; 2023 Nov; 41(11):456.e13-456.e20. PubMed ID: 37640572
[TBL] [Abstract][Full Text] [Related]
8. Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer.
Patel SA; Liu Y; Solanki AA; Baumann BC; Efstathiou JA; Jani AB; Chang AJ; Fischer-Valuck B; Royce TJ
Urol Oncol; 2023 Jul; 41(7):325.e15-325.e23. PubMed ID: 36725382
[TBL] [Abstract][Full Text] [Related]
9. Gynaecological organ involvement in females undergoing radical cystectomy: a multicentre study.
Lobo N; Uthayanan L; Uribe-Lewis S; Issa R; Tay A; Thurairaja R; Nair R; Khan MS; Kusuma M; Abou Chedid W; Moschonas D; Woodhams S; Swinn M; Patil K; Perry M
BJU Int; 2024 Apr; 133(4):474-479. PubMed ID: 38105508
[TBL] [Abstract][Full Text] [Related]
10. Short-Term and Long-Term Morbidity after Radical Cystectomy in Patients with NMIBC and Comparison with MIBC: Identifying Risk Factors for Severe Short-Term Complications.
Haas M; Knobloch C; Mayr R; Gierth M; Pickl C; Engelmann S; Denzinger S; Burger M; Breyer J; Holbach S
Urol Int; 2023; 107(3):246-256. PubMed ID: 36693329
[TBL] [Abstract][Full Text] [Related]
11. Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy.
Okada M; Shindo T; Fujino K; Maeda T; Ito N; Takahashi A; Hotta H; Kunishima Y; Matsukawa M; Takayanagi A; Wanifuchi A; Nofuji S; Kato R; Fukuta F; Hashimoto K; Kobayashi K; Tanaka T; Masumori N
Support Care Cancer; 2023 Oct; 31(10):607. PubMed ID: 37787829
[TBL] [Abstract][Full Text] [Related]
12. Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal Therapy.
Magee DE; Cheung DC; Hird AE; Chung P; Warde P; Catton C; Berlin A; Zlotta A; Fleshner NE; Kulkarni GS
Urol Pract; 2023 Jul; 10(4):293-299. PubMed ID: 37103562
[TBL] [Abstract][Full Text] [Related]
13. Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer.
de Angelis M; Basile G; Scornajenghi CM; Asero V; Del Giudice F; Moschini M
Curr Opin Urol; 2023 Sep; 33(5):354-359. PubMed ID: 37395512
[TBL] [Abstract][Full Text] [Related]
14. SEOM clinical guidelines for the treatment of invasive bladder cancer.
Morales R; Font A; Carles J; Isla D
Clin Transl Oncol; 2011 Aug; 13(8):552-9. PubMed ID: 21821489
[TBL] [Abstract][Full Text] [Related]
15. Myths About Bladder Preservation in Muscle-Invasive Bladder Cancer.
Elumalai T; Joseph N; Choudhury A
Semin Radiat Oncol; 2023 Jan; 33(1):56-61. PubMed ID: 36517194
[TBL] [Abstract][Full Text] [Related]
16. Impact of rural residence on the presentation, management and survival of patients with non-metastatic muscle-invasive bladder carcinoma.
Dursun F; Elshabrawy A; Wang H; Kaushik D; Liss MA; Svatek RS; Gore JL; Mansour AM
Investig Clin Urol; 2023 Nov; 64(6):561-571. PubMed ID: 37932567
[TBL] [Abstract][Full Text] [Related]
17. French AFU Cancer Committee Guidelines - Update 2022-2024: Muscle-Invasive Bladder Cancer (MIBC).
Neuzillet Y; Audenet F; Loriot Y; Allory Y; Masson-Lecomte A; Leon P; Pradère B; Seisen T; Traxer O; Xylinas E; Roumiguié M; Roupret M
Prog Urol; 2022 Nov; 32(15):1141-1163. PubMed ID: 36400480
[TBL] [Abstract][Full Text] [Related]
18. Trimodal therapy versus radical cystectomy for cT2N0M0 urothelial muscle-invasive bladder cancer: Single-center experience.
Fallatah M; Alkahtani AS; Alrumayyan M; Alotaibi MF; Alkhateeb S; Mokhtar AA; Altaweel W
Urol Ann; 2023; 15(4):406-411. PubMed ID: 38074180
[TBL] [Abstract][Full Text] [Related]
19. How Small Can We Go? Partial Bladder Radiation Therapy and Brachytherapy.
Kahn JM; Smits GAHJ; Oosterveld BJ; van der Steen-Banasik EM
Semin Radiat Oncol; 2023 Jan; 33(1):76-81. PubMed ID: 36517197
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of cell cycle protein p53 expression by tumor cells and M2-macrophage infiltration in urinary bladder cancer.
Aljabery F; Shabo I; Saudi A; Holmbom M; Olson H; Jahnson S
Urol Oncol; 2023 Mar; 41(3):148.e9-148.e16. PubMed ID: 36702703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
